Cargando…

FDA-led consortium studies advance quality control of targeted next generation sequencing assays for precision oncology

Cancer is the second leading cause of mortality worldwide despite tremendous advances in treatment. The promise of precision oncology depends on accurate characterization of tumor mutations and subsequent therapy selection. The lack of tumor reference samples along with the associated next generatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Dan, Kusko, Rebecca, Ning, Baitang, Tong, Weida, Johann, Donald J., Xu, Joshua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909622/ https://www.ncbi.nlm.nih.gov/pubmed/35282311 http://dx.doi.org/10.21037/pcm-21-29

Ejemplares similares

Comprehensive Assessments of RNA-seq by the SEQC Consortium: FDA-Led Efforts Advance Precision Medicine
por: Xu, Joshua, et al.
Publicado: (2016)

Artificial intelligence for the next generation of precision oncology
por: Ballester, Pedro J., et al.
Publicado: (2021)

FDA guidance for next generation sequencing-based testing: balancing regulation and innovation in precision medicine
por: Luh, Frank, et al.
Publicado: (2018)

Next‐generation sequencing in precision oncology: Patient understanding and expectations
por: Roberts, J. Scott, et al.
Publicado: (2019)

Alignment of Short Reads: A Crucial Step for Application of Next-Generation Sequencing Data in Precision Medicine
por: Ye, Hao, et al.
Publicado: (2015)

Towards precision oncology in angiosarcomas using next generation “omic” technologies
por: Tan, Grace Fangmin, et al.
Publicado: (2021)

The FDA’s Experience with Emerging Genomics Technologies—Past, Present, and Future
por: Xu, Joshua, et al.
Publicado: (2016)

Ultra-deep multi-oncopanel sequencing of benchmarking samples with a wide range of variant allele frequencies
por: Gong, Binsheng, et al.
Publicado: (2022)

Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations
por: Allegretti, Matteo, et al.
Publicado: (2018)

Next generation DNA led technologies
por: Avadhanam, Sharada, et al.
Publicado: (2016)

Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
por: Deveson, Ira W., et al.
Publicado: (2021)

The Role of Next-Generation Sequencing in Precision Medicine: A Review of Outcomes in Oncology
por: Morash, Margaret, et al.
Publicado: (2018)

Next-generation ctDNA-driven clinical trials in precision immuno-oncology
por: Aggarwal, Charu, et al.
Publicado: (2023)

Clinical validation of the tempus xT next-generation targeted oncology sequencing assay
por: Beaubier, Nike, et al.
Publicado: (2019)

ArrayTrack: a free FDA bioinformatics tool to support emerging biomedical research -- an update
por: Xu, Joshua, et al.
Publicado: (2010)

Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics
por: Zeng, Li, et al.
Publicado: (2021)

Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing
por: Dy, Grace K., et al.
Publicado: (2019)

FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients
por: Wang, Ye, et al.
Publicado: (2021)

Combined Focused Next-Generation Sequencing Assays to Guide Precision Oncology in Solid Tumors: A Retrospective Analysis from an Institutional Molecular Tumor Board
por: Tarawneh, Thomas S., et al.
Publicado: (2022)

Integration Technology of Micro-LED for Next-Generation Display
por: Chen, Dingbo, et al.
Publicado: (2023)

Advancing precision oncology in breast cancer: the FDA approval of elacestrant and Guardant360 CDx: a correspondence
por: Abbasi, Haleema Qayyum, et al.
Publicado: (2023)

Application of next generation sequencing in oncology
por: Meyer, Brian
Publicado: (2014)

Plasma Robot Engineering: The Next Generation of Precision Disease Management
por: Dai, Xiaofeng, et al.
Publicado: (2021)

Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
por: Pritchard, Daryl, et al.
Publicado: (2022)

Two new ArrayTrack libraries for personalized biomedical research
por: Xu, Joshua, et al.
Publicado: (2010)

Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome?
por: Panovska, Dena, et al.
Publicado: (2022)

GeneMed: An Informatics Hub for the Coordination of Next-Generation Sequencing Studies that Support Precision Oncology Clinical Trials
por: Zhao, Yingdong, et al.
Publicado: (2015)

Linking Pharmacogenomic Information on Drug Safety and Efficacy with Ethnic Minority Populations
por: Li, Dan, et al.
Publicado: (2020)

Mining FDA drug labels using an unsupervised learning technique - topic modeling
por: Bisgin, Halil, et al.
Publicado: (2011)

Correction to: Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
Publicado: (2022)

Evolution of Next Generation Therapeutics: Past, Present, and Future of Precision Medicines
por: Ramamoorthy, Anuradha, et al.
Publicado: (2019)

Investigating drug repositioning opportunities in FDA drug labels through topic modeling
por: Bisgin, Halil, et al.
Publicado: (2012)

Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics
por: Hariani, Gunjan D, et al.
Publicado: (2014)

Structural Changes Due to Antagonist Binding in Ligand Binding Pocket of Androgen Receptor Elucidated Through Molecular Dynamics Simulations
por: Sakkiah, Sugunadevi, et al.
Publicado: (2018)

Next-Generation Sequencing in Clinical Oncology: Next Steps Towards Clinical Validation
por: Bennett, Nigel C., et al.
Publicado: (2014)

Bringing the Next Generation of Immuno-Oncology Biomarkers to the Clinic
por: Cesano, Alessandra, et al.
Publicado: (2018)

Evaluation of Bioinformatics Approaches for Next-Generation Sequencing Analysis of microRNAs with a Toxicogenomics Study Design
por: Bisgin, Halil, et al.
Publicado: (2018)

Clinical Next Generation Sequencing for Precision Medicine in Cancer
por: Dong, Ling, et al.
Publicado: (2015)

Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology
por: Zhang, Xuchao, et al.
Publicado: (2019)

Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology
por: Beg, Shaham, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s5eom15h1r3k31kfp9dbva4lvn